Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 125

Results For "bio"

3887 News Found

New support group targets delayed diagnosis of Vasculitis in India
Healthcare | April 20, 2026

New support group targets delayed diagnosis of Vasculitis in India

Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide


Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
Biotech | April 20, 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols


C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
Healthcare | April 20, 2026

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits


Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


AIG Hospitals Chairman Dr D. Nageshwar Reddy elected to elite AIMBE College of Fellows
People | April 18, 2026

AIG Hospitals Chairman Dr D. Nageshwar Reddy elected to elite AIMBE College of Fellows

Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts


Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Policy | April 18, 2026

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines


Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
Supply Chain | April 17, 2026

Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion

The company allocated €56 million to research and development for next-generation line solutions